Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akssira

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
European Journal of Medicinal Chemistry|July 6, 2015
Advances in tetrahydropyrido[1,2-a]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitorsRajâa Boulahjar, Aziz Ouach, Stéphane Bourg, et al.
European Journal of Medicinal Chemistry|March 29, 2016
Novel optimization of valmerins (tetrahydropyrido[1,2-a]isoindolones) as potent dual CDK5/GSK3 inhibitorsAziz Ouach, Rajâa Boulahjar, Christine Vala, et al.
Journal of Medicinal Chemistry|October 23, 2012
Novel tetrahydropyrido[1,2-a]isoindolone derivatives (valmerins): potent cyclin-dependent kinase/glycogen synthase kinase 3 inhibitors with antiproliferative activities and antitumor effects in human tumor xenograftsRajâa Boulahjar, Aziz Ouach, Chiurato Matteo, et al.
Journal of Medicinal Chemistry|December 19, 2013
Design, synthesis, and biological activity of pyridopyrimidine scaffolds as novel PI3K/mTOR dual inhibitorsThibault Saurat, Frédéric Buron, Nuno Rodrigues, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
European Journal of Medicinal Chemistry|July 6, 2015
Advances in tetrahydropyrido[1,2-a]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitorsRajâa Boulahjar, Aziz Ouach, Stéphane Bourg, et al.
European Journal of Medicinal Chemistry|March 29, 2016
Novel optimization of valmerins (tetrahydropyrido[1,2-a]isoindolones) as potent dual CDK5/GSK3 inhibitorsAziz Ouach, Rajâa Boulahjar, Christine Vala, et al.
Journal of Medicinal Chemistry|October 23, 2012
Novel tetrahydropyrido[1,2-a]isoindolone derivatives (valmerins): potent cyclin-dependent kinase/glycogen synthase kinase 3 inhibitors with antiproliferative activities and antitumor effects in human tumor xenograftsRajâa Boulahjar, Aziz Ouach, Chiurato Matteo, et al.
Journal of Medicinal Chemistry|December 19, 2013
Design, synthesis, and biological activity of pyridopyrimidine scaffolds as novel PI3K/mTOR dual inhibitorsThibault Saurat, Frédéric Buron, Nuno Rodrigues, et al.
Pageof 8